Dashboard
Manage Tickers

GRFSGrifols SA

Nasdaq grifols.com


$ 6.32 $ -0.67 (-9.61 %)    

Thursday, 27-Jun-2024 15:59:52 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 482.07 $ 1.24 (0.26 %)
DIA $ 391.62 $ 0.32 (0.08 %)
SPY $ 546.37 $ 0.86 (0.16 %)
TLT $ 93.57 $ 0.37 (0.4 %)
GLD $ 215.08 $ 2.41 (1.13 %)
$ 6.3
$ 6.13
$ 0.00 x 0
$ 0.00 x 0
$ 5.80 - $ 6.33
$ 5.30 - $ 12.15
3,371,536
na
4.33B
$ 0.83
$ 12.97
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

grifols-says-at-end-june-2024-considering-sraas-proceeds-leverage-ratio-is-expected-to-reach-54x-vs-68x-in-march-2024-fcf-in-q2-2024-expected-to-be-positive-contributing-to-reach-5-million-fy24-guidance-which-includes-480-million-of-extraordinary-items-by-end-june-liquidity-will-stand-at-more-than-24-billion-including-sraas-proceeds-is-completely-separate-entity-from-scranton-and-none-of-scrantons-liabilities-are-consolidated-at-cos-group
Grifols Says At End June 2024, Considering...
06/27/2024 16:37:03

- Reuters

grifols-says-16-billion-net-cash-proceeds-from-sale-of-20-equity-stake-in-shanghai-raas-are-currently-deposited-in-cos-bank-account-proceeds-will-be-fully-allocated-to-reduce-2025-senior-secured-notes-and-2027-term-loan-b-and-on-a-pro-rata-basis-as-per-credit-agreement-to-repay-in-full-2025-debt-maturities-leaving-no-additional-maturities-until-2027
Grifols Says €1.6 Billion Net Cash Proceed...
06/27/2024 16:35:25

- Reuters 

levi-strauss-posts-mixed-results-joins-walgreens-aerovironment-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
Levi Strauss Posts Mixed Results, Joins Wa...
06/27/2024 12:33:51

grifols-completes-20-equity-stake-sale-in-sraas-and-inks-partnership-with-haier-group
Grifols Completes 20% Equity Stake Sale In...
06/18/2024 11:37:38

grifols-shares-are-trading-higher-after-the-companys-biotest-received-fda-approval-for-yimmugo-immunoglobulin-to-treat-primary-immunodeficiencies
Grifols shares are trading higher after th...
06/17/2024 11:48:03

grifols-subsidiary-biotest-receives-fda-approval-for-yimmugo-an-intravenous-immunoglobulin-therapeutic-to-treat-primary-immunodeficiencies-with-us-launch-expected-in-second-part-of-2024
Grifols' Subsidiary Biotest Receives FDA A...
06/17/2024 08:26:40

With Biotest-developed Yimmugo, Grifols adds to its remarkable franchise of intravenous and subcutaneous immunoglobulins to m...

grifols-chairman-glanzmann-says-cfo-alfredo-arroyo-to-step-down-role-of-grifols-chairman-will-no-longer-be-executive
Grifols Chairman Glanzmann Says CFO Alfred...
05/14/2024 16:58:25

- Bloomberg

grifols-q1-net-revenues-163-billion-vs-156-billion-yoy-sees-q1-rd-negative-net-investment-905-million-vs-1047-million-yoy-currently-working-to-improve-fcf-guidance-in-light-of-several-ongoing-initiatives-to-hold-investor--analysts-day-on-oct-10
Grifols Q1 Net Revenues €1.63 Billion Vs €...
05/14/2024 15:47:16

- Reuters 

grifols-on-track-to-meet-fy-guidance-and-reduce-debt
Grifols On Track To Meet FY Guidance And R...
05/14/2024 15:39:59

- Reuters

grifols-and-haier-completed-domestic-and-overseas-government-approval-procedures-for-20-stake-transfer-of-sraas
Grifols And Haier Completed Domestic And O...
05/06/2024 10:04:34

grifols-achieves-results-from-phase-4-study-of-fanhdi-in-patients-with-von-willebrand-disease
Grifols Achieves Results From Phase 4 Stud...
04/22/2024 12:37:30

https://www.grifols.com/en/view-news/-/news/grifols-achieves-positive-results-from-phase-4-study-of-fanhdi-double-inactivated-h...

carmax-reports-downbeat-earnings-joins-lovesac-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
CarMax Reports Downbeat Earnings, Joins Lo...
04/11/2024 12:03:24

U.S. stock futures were lower this morning, with the Dow futures falling over 150 points on Thursday.

grifols-says-regarding-adjustments-for-cost-savings-operational-improvements-and-synergies-made-to-consolidated-ebitda-under-credit-agreement-confirms-that-this-is-not-used-as-an-alternative-measure-of-performance
Grifols Says Regarding Adjustments For Cos...
04/04/2024 16:12:58

grifols-achieves-milestone-in-transfusion-medicine-with-ce-mark-for-procleix-arboplex-assay
Grifols Achieves Milestone In Transfusion ...
04/04/2024 08:13:46

Grifols' in vitro nucleic acid test detects four types of arboviruses, helping mitigate the risk of transfusion-transmitt...

why-cutera-shares-are-trading-lower-by-over-26-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Cutera Shares Are Trading Lower By Ove...
03/22/2024 18:39:16

Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected four...

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
03/22/2024 13:06:12

lululemon-issues-weak-outlook-joins-nike-and-other-big-stocks-moving-lower-in-fridays-pre-market-session
Lululemon Issues Weak Outlook, Joins Nike ...
03/22/2024 09:40:40

U.S. stock futures were higher this morning, with the Dow futures gaining by around 0.1% on Friday.

spanish-stock-market-supervisor-cnmv-says-there-were-also-deficiencies-in-the-presentation-of-alternative-performance-measures-in-particular-ebitda-and-debtebitda-ratio-cnmv-sees-no-need-for-grifols-to-restate-accounts-says-at-present-its-not-possible-to-prejudge-potential-consequences-of-any-sanctions-for-grifols
Spanish Stock Market Supervisor CNMV Says ...
03/21/2024 18:59:20

- Reuters

spanish-stock-market-supervisor-cnmv-says-however-we-have-found-deficiencies-in-detail-accuracy-of-breakdowns-explanatory-notes-in-some-years-of-the-period-analyzed
Spanish Stock Market Supervisor CNMV Says ...
03/21/2024 18:57:24

- Reuters

spanish-stock-market-supervisor-cnmv-says-investigations-not-identified-significant-errors-in-quantitative-magnitudes-of-grifols-main-financial-statements-for-the-period-analyzed-have-not-found-evidence-that-the-financial-debt-reported-by-grifols-does-not-correspond-to-reality
Spanish Stock Market Supervisor CNMV Says ...
03/21/2024 18:57:17

- Reuters

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)